Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers S > Headlines for Sangamo Biosciences Inc. > News item |
Sangamo Biosciences investor sells 206,105 shares, keeps 5.52% stake
By Lisa Kerner
Charlotte, N.C., May 26 - A group of Sangamo Biosciences, Inc. investors led by Kopp Investment Advisors, LLC sold 206,105 shares of the company's stock between March 16 and May 15 priced from $3.41 to $4.73 each.
The transactions were reported in a schedule 13D/A filed on Tuesday with the Securities and Exchange Commission.
Kopp beneficially owns 2,267,755 shares, or 5.52%, of the Richmond, Calif., company that develops novel DNA-binding proteins for therapeutic gene regulation and modification.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.